Llwytho...
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
Temozolomide (TMZ) resistance is a complication of treatment of glioma, and new strategies are urgently required to overcome chemoresistance in glioma cells. In the present study, it was demonstrated that tripartite motif-containing 31 (TRIM31) was abnormally upregulated in glioma tissues and cell l...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Exp Ther Med |
|---|---|
| Prif Awduron: | , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
D.A. Spandidos
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388422/ https://ncbi.nlm.nih.gov/pubmed/32765650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8782 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|